GAS7 Deficiency Promotes Metastasis in MYCN-driven Neuroblastoma

One of the greatest barriers to curative treatment of neuroblastoma (NB) is its frequent metastatic outgrowth prior to diagnosis, especially in cases driven by amplification of the MYCN oncogene. However, only a limited number of regulatory proteins that contribute to this complex MYCN-mediated proc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Res
Main Authors: Dong, Zhiwei, Yeo, Kok Siong, Lopez, Gonzalo, Zhang, Cheng, Eggum, Erin N. Dankert, Rokita, Jo Lynne, Ung, Choong Yong, Levee, Taylor M., Her, Zuag Paj, Howe, Cassie J., Hou, Xiaonan, van Ree, Janine H., Li, Shuai, He, Shuning, Tao, Ting, Fritchie, Karen, Torres-Mora, Jorge, Lehman, Julia S., Meves, Alexander, Razidlo, Gina L., Rathi, Komal S., Weroha, S. John, Look, A. Thomas, van Deursen, Jan M., Li, Hu, Westendorf, Jennifer J., Maris, John M., Zhu, Shizhen
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8178188/
https://ncbi.nlm.nih.gov/pubmed/33602789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-1890
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares